Marker Therapeutics, Inc. MRKR Q1 2026 earnings

FAQ

When did Marker Therapeutics, Inc. report Q1 2026 earnings?

Marker Therapeutics, Inc. (MRKR) reported Q1 2026 earnings on May 15, 2026 after market close.

What were Marker Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Marker Therapeutics, Inc. reported eps of $-0.16 for Q1 2026.

Did Marker Therapeutics, Inc. beat estimates in Q1 2026?

EPS beat the consensus estimate of $-0.18 by $0.02.

How did Marker Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 40.7% from $-0.27.

Where can I find Marker Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 10-Q periodic report (0001104659-26-062763) directly on SEC EDGAR. The filing index links above go to sec.gov.